A phase II study of dasatinib and dexamethasone as primary therapy followed by transplantation for adults with newly diagnosed PH/BCR-ABL1-positive acute lymphoblastic leukemia: Final results of Alliance/CALGB study 10701
- Citation:
- Blood vol 132 (suppl 1) abstr 309
- Meeting Instance:
- ASH 2018
- Year:
- 2018
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3410
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U10CA180861, U24CA196171, U10CA180820, U10CA180888
- Corr. Author:
- Authors:
- Matthew J. Wieduwilt Jun Yin Meir Wetzler Geoff Uy Bayard L. Powell Jonathan Kolitz Michaela Liedtke Wendy Stock Jan H. Beumer Ryan J. Mattison Elizabeth Storrick Steven Devine Scott Smith Richard M. Stone Richard A. Larson
- Networks:
- IL017, LAPS-IL057, LAPS-MA036, LAPS-MD017, LAPS-MO011, LAPS-OH007, LAPS-WI020, NC002, NORTHWELL
- Study
- CALGB-10701
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: